Skip to content

Clinical trials

Bipolar Disorder trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bipolar Disorder Country / region: Poland Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20043
20052
20061
20081
20093
20122
20131
20141
20161
20192
20221
20231
20242
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Recruiting4
Terminated2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma America, Inc.5
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
AstraZeneca2
Jakub Antczak2
Medical University of Gdansk2
Bristol-Myers Squibb1
Celon Pharma SA1
Forest Laboratories1
H. Lundbeck A/S1
Janssen Pharmaceutica N.V., Belgium1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bipolar Disorder23
Mania3
Autistic Disorder2
Depressive Disorder2
Schizophrenia2
Anhedonia1
Attention Deficit Disorder with Hyperactivity1
Cognitive Dysfunction1
Depressive Disorder, Treatment-Resistant1
Fatigue1

Trials

Showing 76 to 23 of 23. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.